Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema.
about
Selective inhibition of retinal angiogenesis by targeting PI3 kinaseInhibition of choroidal neovascularization by topical application of angiogenesis inhibitor vasostatin.Topical application of recombinant calreticulin peptide, vasostatin 48, alleviates laser-induced choroidal neovascularization in rats.Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization.SU5416 induces premature senescence in endothelial progenitor cells from patients with age-related macular degeneration.Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications.Antiangiogenic effects of topically administered multiple kinase inhibitor, motesanib (AMG 706), on experimental choroidal neovascularization in mice.Optical coherence tomography: history, current status, and laboratory work.An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology.Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia.Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit.Topical antiangiogenic SRPK1 inhibitors reduce choroidal neovascularization in rodent models of exudative AMDCharacteristic findings of optical coherence tomography in retinal angiomatous proliferationRecent perspectives in ocular drug delivery.Emerging therapeutic approaches in the management of retinal angiogenesis and edema.Diabetic macular edema: current and emerging therapies.Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye.Anti-angiogenic Therapy for Retinal Disease.Application of multiplex immunoassay technology to investigations of ocular disease.The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization.Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy.Topical Drug Delivery to the Posterior Segment of the Eye: Addressing the Challenge of Preclinical to Clinical Translation
P2860
Q28471888-DB292F48-5E5E-4F36-865D-AA83FD3B598CQ33505319-6F81C8DD-8813-4E90-B9D7-922835977198Q33573595-93B5AFB1-7D7D-400D-8979-3B825213C255Q33868764-99D7B8FF-32FF-43A1-85B5-C98A8CF6C08CQ34493854-85549C66-4DB7-4EA4-B9C2-98E7E3EF94FDQ34701929-67AE80C1-55D4-4140-B955-357A3BB1848DQ34862792-B4676F63-AFEC-43F8-BD56-16D71399B580Q34936736-43F23129-7427-4F3E-91FD-30A7FBFA6D9FQ35076957-BF17A06E-B278-41C8-A5E7-7670F78104ABQ35600243-9700881F-E21D-46D5-8018-66B2BB97DE83Q36573796-AAB8DDEF-17F1-45CD-B32F-2EFB0CD90E59Q37166978-C95E8109-6825-446C-952A-ED6196035F28Q37196177-D9D916EB-52B3-4D6A-8062-B3A3136B476DQ37256549-749C3006-9650-45D9-8A9D-518B41C65838Q37822290-F8898586-01BB-4BC5-BC15-45805BD6B68BQ37985854-D809A1F9-BC45-4EE3-9AD9-2888AF2B3AC1Q38279950-3EB61620-0BCF-4FDF-A665-BBA9197D689FQ38805247-ED42A497-26ED-4673-8771-A684CDC072DCQ38941639-E2254660-B0A5-4C3E-B51C-6E2AC575843DQ39076235-D26D8C9F-8BE3-4C9F-ADDA-015EA6EBAE36Q39103248-8CD1CF46-C742-4623-BE30-089B299A76DAQ58106414-CC7A19B2-9043-4625-A610-1FF74D85DC37
P2860
Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Topical administration of a mu ...... ularization and retinal edema.
@ast
Topical administration of a mu ...... ularization and retinal edema.
@en
Topical administration of a mu ...... ularization and retinal edema.
@nl
type
label
Topical administration of a mu ...... ularization and retinal edema.
@ast
Topical administration of a mu ...... ularization and retinal edema.
@en
Topical administration of a mu ...... ularization and retinal edema.
@nl
prefLabel
Topical administration of a mu ...... ularization and retinal edema.
@ast
Topical administration of a mu ...... ularization and retinal edema.
@en
Topical administration of a mu ...... ularization and retinal edema.
@nl
P2093
P2860
P356
P1476
Topical administration of a mu ...... cularization and retinal edema
@en
P2093
Adrienne Racanelli-Layton
Glenn Noronha
Hideo Akiyama
John Doukas
Katsutoshi Yokoi
Luis Dellamary
Michael Martin
P2860
P356
10.1002/JCP.21426
P577
2008-07-01T00:00:00Z